The Influence of Two Priming Doses of Different Anti-COVID-19 Vaccines on the Production of Anti-SARS-CoV-2 Antibodies After the Administration of the Pfizer/BioNTech Booster.
Blanka Wolszczak BiedrzyckaAnna BieńkowskaElwira Smolińska-FijołekGrzegorz BiedrzyckiJustyna DorfPublished in: Infection and drug resistance (2022)
The study revealed that persons who received three doses of the Pfizer/BioNTech vaccine had significantly higher antibody titers than those who received two doses of AstraZeneca and a booster dose of Pfizer/BioNTech.